This inventor holds 2 USPTO granted patents and 3 published patent applications and 1 EPO patent. Top assignee: Allgenesis Biotherapeutics Inc.. Active years: 2021-2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2021-2024
Title: Innovations by Jia-Hau Shiu
Introduction
Jia-Hau Shiu is a notable inventor based in Taipei, Taiwan. He has made significant contributions to the field of biotherapeutics, particularly in the area of angiogenesis inhibition. With a total of 2 patents to his name, Shiu's work is paving the way for advancements in medical treatments.
Latest Patents
One of his latest patents focuses on fusion proteins for inhibiting angiogenesis. This invention relates to biologics that inhibit angiogenesis, specifically through fusion proteins that target the integrin activated pathway and another angiogenic factor-activated pathway. The patent details the compositions of these fusion proteins, as well as methods for their production and application.
Career Highlights
Jia-Hau Shiu is currently associated with Allgenesis Biotherapeutics Inc., where he continues to innovate and develop new therapeutic solutions. His work is crucial in the ongoing fight against diseases that involve abnormal blood vessel growth.
Collaborations
Shiu collaborates with talented individuals such as Pei-Tzu Wu and Tan Nguyen, contributing to a dynamic research environment that fosters innovation and discovery.
Conclusion
Jia-Hau Shiu's contributions to the field of biotherapeutics through his patents and collaborations highlight his role as a key innovator in medical science. His work continues to inspire advancements in the treatment of various health conditions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile